FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155387787> ?p ?o ?g. }

• W2155387787 endingPage "314" @default.
• W2155387787 startingPage "305" @default.
• W2155387787 abstract "Cisplatin-based concurrent chemoradiotherapy (CCRT) is a standard treatment for cervical cancer, but nedaplatin-based CCRT is not routinely administered. We evaluated the efficacy and safety of nedaplatin-based CCRT (35 mg/m2 weekly) and analyzed prognostic factors for survival among 52 patients with International Federation of Gynecology and Obstetrics (FIGO) Stage IB2–IVA cervical cancer treated from 1999 to 2009. Patients were treated with a combination of external beam radiotherapy of 40–56 Gy (in 20–28 fractions) and 13.6–28.8 Gy (in 2–4 fractions) of high-dose-rate (HDR) intracavitary brachytherapy or 18 Gy (in 3 fractions) of HDR interstitial brachytherapy. Overall survival (OS), progression-free survival (PFS), and local control (LC) were estimated using the Kaplan–Meier method. The Cox proportional hazard model was used for multivariate analysis. Acute and late toxicities were evaluated using the Common Terminology Criteria for Adverse Events version 4.0. The median follow-up period was 52 months. The median patient age was 63 years. The 5-year OS, PFS and LC rates were 78%, 57% and 73%, respectively. Multivariate analysis showed that histologic type, maximum tumor diameter, and pretreatment hemoglobin level were independent risk factors for PFS. Regarding adverse effects, 24 patients (46%) had acute Grade 3–4 leukopenia and 5 (10%) had late Grade 3 gastrointestinal toxicities. No patient experienced renal toxicity. Nedaplatin-based CCRT for FIGO Stage IB2–IVA cervical cancer was efficacious and safe, with no renal toxicity. Histologic type, maximum tumor diameter, and pretreatment hemoglobin level were statistically significant prognostic factors for PFS." @default.
• W2155387787 created "2016-06-24" @default.
• W2155387787 creator A5000243750 @default.
• W2155387787 creator A5013224788 @default.
• W2155387787 creator A5016405761 @default.
• W2155387787 creator A5032281643 @default.
• W2155387787 creator A5039467530 @default.
• W2155387787 creator A5051543374 @default.
• W2155387787 creator A5055405608 @default.
• W2155387787 creator A5059947593 @default.
• W2155387787 creator A5085915789 @default.
• W2155387787 creator A5090684583 @default.
• W2155387787 date "2014-11-26" @default.
• W2155387787 modified "2023-10-02" @default.
• W2155387787 title "Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors" @default.
• W2155387787 cites W1963528687 @default.
• W2155387787 cites W1967858286 @default.
• W2155387787 cites W1971646270 @default.
• W2155387787 cites W1971828436 @default.
• W2155387787 cites W1976476968 @default.
• W2155387787 cites W1977479761 @default.
• W2155387787 cites W1980121954 @default.
• W2155387787 cites W2013567354 @default.
• W2155387787 cites W2018047741 @default.
• W2155387787 cites W2023437837 @default.
• W2155387787 cites W2028550769 @default.
• W2155387787 cites W2038881913 @default.
• W2155387787 cites W2041696911 @default.
• W2155387787 cites W2045938900 @default.
• W2155387787 cites W2048865077 @default.
• W2155387787 cites W2056567773 @default.
• W2155387787 cites W2059910638 @default.
• W2155387787 cites W2070266241 @default.
• W2155387787 cites W2080309100 @default.
• W2155387787 cites W2087737403 @default.
• W2155387787 cites W2089608390 @default.
• W2155387787 cites W2106208059 @default.
• W2155387787 cites W2122321342 @default.
• W2155387787 cites W2131860931 @default.
• W2155387787 cites W2142450264 @default.
• W2155387787 cites W2314753133 @default.
• W2155387787 cites W2324392028 @default.
• W2155387787 cites W2335492933 @default.
• W2155387787 cites W2419236420 @default.
• W2155387787 cites W2480089904 @default.
• W2155387787 doi "https://doi.org/10.1093/jrr/rru101" @default.
• W2155387787 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4380049" @default.
• W2155387787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25428244" @default.
• W2155387787 hasPublicationYear "2014" @default.
• W2155387787 type Work @default.
• W2155387787 sameAs 2155387787 @default.
• W2155387787 citedByCount "16" @default.
• W2155387787 countsByYear W21553877872015 @default.
• W2155387787 countsByYear W21553877872016 @default.
• W2155387787 countsByYear W21553877872017 @default.
• W2155387787 countsByYear W21553877872018 @default.
• W2155387787 countsByYear W21553877872019 @default.
• W2155387787 countsByYear W21553877872021 @default.
• W2155387787 countsByYear W21553877872022 @default.
• W2155387787 countsByYear W21553877872023 @default.
• W2155387787 crossrefType "journal-article" @default.
• W2155387787 hasAuthorship W2155387787A5000243750 @default.
• W2155387787 hasAuthorship W2155387787A5013224788 @default.
• W2155387787 hasAuthorship W2155387787A5016405761 @default.
• W2155387787 hasAuthorship W2155387787A5032281643 @default.
• W2155387787 hasAuthorship W2155387787A5039467530 @default.
• W2155387787 hasAuthorship W2155387787A5051543374 @default.
• W2155387787 hasAuthorship W2155387787A5055405608 @default.
• W2155387787 hasAuthorship W2155387787A5059947593 @default.
• W2155387787 hasAuthorship W2155387787A5085915789 @default.
• W2155387787 hasAuthorship W2155387787A5090684583 @default.
• W2155387787 hasBestOaLocation W21553877871 @default.
• W2155387787 hasConcept C121608353 @default.
• W2155387787 hasConcept C126322002 @default.
• W2155387787 hasConcept C126894567 @default.
• W2155387787 hasConcept C143998085 @default.
• W2155387787 hasConcept C146357865 @default.
• W2155387787 hasConcept C151730666 @default.
• W2155387787 hasConcept C197934379 @default.
• W2155387787 hasConcept C2776694085 @default.
• W2155387787 hasConcept C2777416452 @default.
• W2155387787 hasConcept C2777793932 @default.
• W2155387787 hasConcept C2778203143 @default.
• W2155387787 hasConcept C2778220009 @default.
• W2155387787 hasConcept C2778239845 @default.
• W2155387787 hasConcept C2778424827 @default.
• W2155387787 hasConcept C50382708 @default.
• W2155387787 hasConcept C509974204 @default.
• W2155387787 hasConcept C71924100 @default.
• W2155387787 hasConcept C86803240 @default.
• W2155387787 hasConceptScore W2155387787C121608353 @default.
• W2155387787 hasConceptScore W2155387787C126322002 @default.
• W2155387787 hasConceptScore W2155387787C126894567 @default.
• W2155387787 hasConceptScore W2155387787C143998085 @default.
• W2155387787 hasConceptScore W2155387787C146357865 @default.
• W2155387787 hasConceptScore W2155387787C151730666 @default.
• W2155387787 hasConceptScore W2155387787C197934379 @default.
• W2155387787 hasConceptScore W2155387787C2776694085 @default.

• next